drugset / Trial / NCT02172235
Relative Bioavailability of Pioglitazone After Co-administration With Different Doses of BI 10773 in Healthy Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
The objective was to investigate the effect of different doses of BI 10773 on the bioavailability of pioglitazone after multiple oral doses of both drugs
Timeline
- Start
- 2010-04
- Primary completion
- 2010-07
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Empagliflozin | Small molecule | — | Oral |
| Subject | Pioglitazone | Small molecule | — | Oral |
Indications
No indication recorded.